financetom
Business
financetom
/
Business
/
Goldman Sachs poised to buy into ice cream maker Froneri at $17.13 billion valuation, FT says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman Sachs poised to buy into ice cream maker Froneri at $17.13 billion valuation, FT says
Jul 31, 2025 9:52 PM

(Reuters) -Goldman Sachs ( GS ) is poised to buy into ice cream maker Froneri at a 15-billion-euro ($17.13 billion) valuation including debt, the Financial Times reported on Friday.

Reuters could not immediately verify the report.

The deal, which could be signed as soon as September, would involve Goldman's asset management division becoming the lead investor in a continuation vehicle established by French private equity firm PAI Partners, the report said citing sources.

Froneri is a joint venture between Switzerland-based Nestle and PAI unit R&R Ice Cream, set up in 2016, with the two merging their European ice cream business in 20 countries.

Nestle also sold its U.S. ice cream business to Froneri in 2019 in a $4 billion-deal, giving it control of Häagen-Dazs and other Nestle brands.

Goldman Sachs ( GS ) and Nestle did not immediately respond to Reuters' requests for comment, while PAI and Froneri could not be immediately reached for comment.

($1 = 0.8759 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exlservice Holdings Insider Sold Shares Worth $911,285, According to a Recent SEC Filing
Exlservice Holdings Insider Sold Shares Worth $911,285, According to a Recent SEC Filing
Aug 23, 2024
05:27 PM EDT, 08/23/2024 (MT Newswires) -- Anita Mahon, Executive Vice President & Business Head, Healthcare, on August 21, 2024, sold 25,670 shares in Exlservice Holdings ( EXLS ) for $911,285. Following the Form 4 filing with the SEC, Mahon has control over a total of 68,857 shares of the company, with 68,857 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1297989/000162828024038371/xslF345X05/wk-form4_1724448254.xml ...
Market Chatter: Johnson & Johnson Unveils New Strategy on Hospital Drug-Discount Program
Market Chatter: Johnson & Johnson Unveils New Strategy on Hospital Drug-Discount Program
Aug 23, 2024
02:29 PM EDT, 08/23/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) informed certain hospitals that they will have to pay full price for two drugs the company sold under the drug-savings program and can then apply for rebates, the Wall Street Journal reported Friday. The switch, which would take effect on Oct. 15, would mark a drastic change...
Centessa Pharmaceuticals Insider Sold Shares Worth $573,905, According to a Recent SEC Filing
Centessa Pharmaceuticals Insider Sold Shares Worth $573,905, According to a Recent SEC Filing
Aug 23, 2024
05:19 PM EDT, 08/23/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on August 23, 2024, sold 46,651 shares in Centessa Pharmaceuticals ( CNTA ) for $573,905. Following the Form 4 filing with the SEC, Saha has control over a total of 814,924 shares of the company, with 776,924 shares held directly and 38,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1847903/000184790324000137/xslF345X05/wk-form4_1724447584.xml...
Toronto-Dominion Bank's Fiscal Q3 Adjusted Earnings, Revenue Rise
Toronto-Dominion Bank's Fiscal Q3 Adjusted Earnings, Revenue Rise
Aug 23, 2024
06:25 AM EDT, 08/22/2024 (MT Newswires) -- Toronto-Dominion Bank ( MLWIQXX ) reported fiscal Q3 adjusted earnings Thursday of 2.05 Canadian dollars ($1.51) per diluted share, up from CA$1.95 a year earlier. Analysts polled by Capital IQ expected CA$2.08. Total revenue for the fiscal quarter ended July 31, expressed as the sum of net interest income and non-interest income, was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved